Mutagenesis induced by the nitric oxide donor sodium nitroprusside in mouse cells

Mutagenesis

Volumn 22, Issue 1, 2007, Pages 63-67

  Lee, Dong Hyun ^a   Pfeifer, Gerd P ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; FIBROBLAST; GENE FREQUENCY; GENE MUTATION; MAMMAL CELL; MOUSE; MUTAGENICITY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SPECTRUM; STATISTICAL ANALYSIS;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; EMBRYO; FIBROBLASTS; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTAGENESIS; NITRIC OXIDE DONORS; NITRITES; NITROPRUSSIDE; TRANSCRIPTION FACTORS; TRANSGENES; VIRAL PROTEINS;

MAMMALIA;

EID: 33846100157     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/gel051     Document Type: Article

References (46)

1. Kerwin,J.F.Jr, Lancaster,J.R.Jr and Feldman,P.L. (1995) Nitric oxide: a new paradigm for second messengers. J. Med. Chem., 38, 4343-4362.
2. Moncada,S., Palmer,R.M. and Higgs,E.A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev., 43, 109-142.
3. Nathan,C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J., 6, 3051-3064.
4. Liu,R.H. and Hotchkiss,J.H. (1995) Potential genotoxicity of chronically elevated nitric oxide: a review. Mutat. Res., 339, 73-89.
5. Beckman,J.S. (1991) The double-edged role of nitric oxide in brain function and superoxide-mediated injury. J. Dev. Physiol., 15, 53-59.
6. Schmidt,H.H., Warner,T.D. and Murad,F. (1992) Double-edged role of ndogenous nitric oxide. Lancet, 339, 986.
7. Asaka,M., Takeda,H., Sugiyama,T. and Kato,M. (1997) What role does elicobacter pylori play in gastric cancer? Gastroenterology, 113, 56-S60.
8. Hussain,S.P., Hofseth,L.J. and Harris,C.C. (2003) Radical causes of cancer. Nat. Rev. Cancer, 3, 276-285.
9. Wink,D.A., Vodovotz,Y., Laval,J., Laval,F., Dewhirst,M.W. and Mitchell,J.B. (1998) The multifaceted roles of nitric oxide in cancer. Carcinogenesis, 19, 711-721.
10. Farrell,R.J. and Peppercorn,M.A. (2002) Ulcerative colitis. Lancet, 359, 331-340.
11. deRojas-Walker,T., Tamir,S., Ji,H., Wishnok,J.S. and Tannenbaum,S.R. (1995) Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. Chem. Res. Toxicol., 8, 473-477.
12. Wink,D.A., Kasprzak,K.S. and Maragos,C.M. et al. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science, 254, 1001-1003.
13. Arroyo,P.L., Hatch-Pigott,V., Mower,H.F. and Cooney,R.V. (1992) Mutagenicity of nitric oxide and its inhibition by antioxidants. Mutat. Res., 281, 193-202.
14. Maragos,C.M., Andrews,A.W., Keefer,L.K. and Elespuru,R.K. (1993) Mutagenicity of glyceryl trinitrate (nitroglycerin) in Salmonella typhimurium. Mutat. Res., 298, 187-195.
15. Nguyen,T., Brunson,D., Crespi,C.L., Penman,B.W., Wishnok,J.S. and Tannenbaum,S.R. (1992) DNA damage and mutation in human cellsexposed to nitric oxide in vitro. Proc. Natl Acad. Sci. USA,+ 89, 3030-3034.
16. Andreassi,M.G., Picano,E., Del Ry,S., Botto,N., Colombo,M.G., Giannessi,D., Lubrano,V., Vassalle,C. and Biagini,A. (2001) Chronic long-term nitrate therapy: possible cytogenetic effect in humans? Mutagenesis, 16, 517-521.
17. Lin,W., Wei,X., Xue,H., Kelimu,M., Tao,R., Song,Y. and Zhou,Z. (2000) Study on DNA strand breaks induced by sodium nitroprusside, a nitric oxide donor, in vivo and in vitro. Mutat. Res., 466, 187-195.
18. Lin,W., Xue,H., Liu,S., He,Y., Fu,J. and Zhou,Z. (1998) Genotoxicity of nitric oxide produced from sodium nitroprusside. Mutat. Res., 413, 121-127.
19. Sandhu,J.K. and Birnboim,H.C. (1997) Mutagenicity and cytotoxicity of reactive oxygen and nitrogen species in the MN-11 murine tumor cell line. Mutat. Res., 379, 241-252.
20. Green,L.C., Wagner,D.A., Glogowski,J., Skipper,P.L., Wishnok,J.S. and Tannenbaum,S.R. (1982) Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem., 126, 131-138.
21. Jakubczak,J.L., Merlino,G., French,J.E., Muller,W.J., Paul,B., Adhya,S. and Garges,S. (1996) Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc. Natl Acad. Sci. USA, 93, 9073-9078.
22. Herskowitz,I. and Hagen,D. (1980) The lysis-lysogeny decision of phage lambda: explicit programming and responsiveness. Annu. Rev. Genet., 14, 399-445.
23. Ignarro,L.J., Fukuto,J.M., Griscavage,J.M., Rogers,N.E. and Byrns,R.E. (1993) Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc. Natl Acad. Sci. USA, 90, 8103-8107.
24. Birnboim,H.C. and Privora,H. (2000) Depletion of intracellular glutathione reduces mutations by nitric oxide-donating drugs. Nitric Oxide, 4, 496-504.
25. Besaratinia,A., Bates,S.E. and Pfeifer,G.P. (2002) Mutational signature of the proximate bladder carcinogen N-hydroxy-4-acetylaminobiphenyl: inconsistency with the p53 mutational spectrum in bladder cancer. Cance Res., 62, 4331-4338.
26. Besaratinia,A. and Pfeifer,G.P. (2004) Genotoxicity of acrylamide and glycidamide. J. Natl Cancer Inst., 96, 1023-1029.
27. Besaratinia,A. and Pfeifer,G.P. (2005) Investigating DNA adduct-targeted mutagenicity of tamoxifen: preferential formation of tamoxifen-DNA adducts in the human p53 gene in SV40 immortalized hepatocytes but not endometrial carcinoma cells. Biochemistry, 44, 8418-8427.
28. Davies,R., Gant,T.W., Smith,L.L. and Styles,J.A. (1999) Tamoxifen induces G:C!T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 50-CpG-30 dinucleotide sequences as found in the lacI transgene. Carcinogenesis, 20, 1351-1356.
29. Harbach,P.R., Zimmer,D.M., Filipunas,A.L., Mattes,W.B. and Aaron,C.S. (1999) Spontaneous mutation spectrum at the lambda cII locus in liver, lung, and spleen tissue of Big Blue transgenic mice. Environ. Mol. Mutagen., 33, 132-143.
30. Routledge,M.N. (2000) Mutations induced by reactive nitrogen oxide species in the supF forward mutation assay. Mutat. Res., 450, 95-105.
31. Routledge,M.N., Wink,D.A., Keefer,L.K. and Dipple,A. (1994) DNA sequence changes induced by two nitric oxide donor drugs in the supF assay. Chem. Res. Toxicol., 7, 628-632.
32. Eritja,R., Horowitz,D.M., Walker,P.A., Ziehler-Martin,J.P., Boosalis,M.S., Goodman,M.F., Itakura,K. and Kaplan,B.E. (1986) Synthesis and properties of oligonucleotides containing 20-deoxynebularine and 20-deoxyxanthosine. Nucleic Acids Res., 14, 8135-8153.
33. Kamiya,H., Shimizu,M., Suzuki,M., Inoue,H. and Ohtsuka,E. (1992) Mutation induced by deoxyxanthosine in codon 12 of a synthetic c-Ha-ras gene. Nucleosides Nucleotides, 11, 247-260.
34. Vongchampa,V., Dong,M., Gingipalli,L. and Dedon,P. (2003) Stability of 20-deoxyxanthosine in DNA. Nucleic Acids Res., 31, 1045-1051.
35. Wuenschell,G.E., O'Connor,T.R. and Termini,J. (2003) Stability, miscoding potential, and repair of 20-deoxyxanthosine in DNA: implications for nitric oxide-induced mutagenesis. Biochemistry, 42, 3608-3616.
36. Dong,M., Wang,C., Deen,W.M. and Dedon,P.C. (2003) Absence of 20-deoxyoxanosine and presence of abasic sites in DNA exposed to nitric oxide at controlled physiological concentrations. Chem. Res. Toxicol., 16, 1044-1055.
37. Suzuki,T., Ide,H., Yamada,M., Endo,N., Kanaori,K., Tajima,K., Morii,T. and Makino,K. (2000) Formation of 20-deoxyoxanosine from 20-deoxyguanosine and nitrous acid: mechanism and intermediates. Nucleic Acids Res., 28, 544-551.
38. Nakano,T., Asagoshi,K., Terato,H., Suzuki,T. and Ide,H. (2005) Assessment of the genotoxic potential of nitric oxide-induced guanine lesions by in vitro reactions with Escherichia coli DNA polymerase I. Mutagenesis, 20, 209-216.
39. Dong,M. and Dedon,P.C. (2006) Relatively small increases in the steadystate levels of nucleobase deamination products in DNA from human TK6 cells exposed to toxic levels of nitric oxide. Chem. Res. Toxicol., 19, 50-57.
40. Dedon,P.C. and Tannenbaum,S.R. (2004) Reactive nitrogen species in the chemical biology of inflammation. Arch. Biochem. Biophys., 423, 12-22.
41. Niles,J.C., Wishnok,J.S. and Tannenbaum,S.R. (2006) Peroxynitriteinduced oxidation and nitration products of guanine and 8-oxoguanine: structures and mechanisms of product formation. Nitric Oxide, 14, 109-121.
42. Ramakrishna Rao,D.N. and Cederbaum,A.I. (1996) Generation of reactive xygen species by the redox cycling of nitroprusside. Biochim. Biophys. Acta, 1289, 195-202.
43. Routledge,M.N., Mirsky,F.J., Wink,D.A., Keefer,L.K. and Dipple,A. (1994) Nitrite-induced mutations in a forward mutation assay: influence of nitrite concentration and pH. Mutat. Res., 322, 341-346.
44. Burney,S., Niles,J.C., Dedon,P.C. and Tannenbaum,S.R. (1999) DNA damage in deoxynucleosides and oligonucleotides treated with peroxynitrite. Chem. Res. Toxicol., 12, 513-520.
45. Jeong,J.K., Juedes,M.J. and Wogan,G.N. (1998) Mutations induced in the supF gene of pSP189 by hydroxyl radical and singlet oxygen: relevance to eroxynitrite mutagenesis. Chem. Res. Toxicol., 11, 550-556.
46. Juedes,M.J. and Wogan,G.N. (1996) Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. Mutat. Res., 349, 51-61